معرفی
Carol A. Carter is a Distinguished Professor in the Department of Microbiology and Immunology at Stony Brook University and holds an adjunct appointment in the Department of Physiology & Biophysics. She is a Member of the National Academy of Sciences with a Ph.D. from Yale University (1972).
Her educational background includes:
- Ph.D. in Molecular Biophysics and Biochemistry, Yale University (1972)
Dr. Carter's research focuses on viral assembly mechanisms of HIV, EBV, and SARS-CoV-2, investigating how viral proteins recruit host cellular machinery like the ESCRT complex and Tsg101 for budding and egress. Her work integrates molecular genetics, biochemistry, and computational approaches to identify antiviral targets, with emphasis on repurposing FDA-approved drugs and overcoming protease inhibitor resistance.
Her recent publications (2020) demonstrate cross-viral applicability of targeting host factors like Tsg101 and CCDC11, revealing conserved mechanisms across HIV, SARS-CoV-2, and Ebola virus that enable broad-spectrum antiviral strategies.
Scientific recognition includes:
- Election to the National Academy of Sciences
Her collaborative research bridges structural biology, medicinal chemistry, and computational modeling to develop novel therapeutics targeting viral assembly pathways, with implications for pandemic preparedness against emerging pathogens.
